同时患艾滋病和白血病的美国男子骨髓移植后“起死回生” 变异基因打开“抗艾”新思路 康生丹因免疫调控治疗艾滋病 美国男子艾滋病成功被治愈

评论
4 views

  • 价值中国
  • 新兴产业
  • 生物/医药
  • 同时患艾滋病和白血病的美国男子骨髓移植后“起死回生” 变异基因打开“抗艾”新思路 康生丹因免疫调控治疗艾滋病 美国男子艾滋病成功被治愈

美国男子艾滋病成功被治愈

 
　
　
　
 

美国男子艾滋病成功被治愈
    http://www.sina.com.cn  2010年12月17日 16:24  长江商报

　
图示∶2010年12月即将出版的《中国特色医疗金鉴》登载的刘君主任及其机构　
　
 

慢性艾滋病早期中医药治疗保障生命论证
 

　　现在网消息 作为一种破坏人体免疫系统的疾病，艾滋病一直是困扰世界医学界的难题，目前还没有一种有效的方法能够治愈它。然而据美联社12月15日报道，德国研究人员近日在新一期美国《血液》月刊上发表报告称，他们通过骨髓移植疗法成功治愈了一名白血病患者的艾滋病。但这一疗法能否推广引发争议。

　　骨髓移植治愈艾滋

　　德国柏林沙里泰医院的研究人员托马斯·施奈德介绍说，美国一名40多岁的白血病患者2007年打算接受骨髓移植。他同时是一名艾滋病病毒携带者。这名患者的主治医生许特尔当时冒出一个大胆的想法：“为什么不同时治愈这两种疾病呢？”

　　其实，尽管艾滋病对一些人而言意味着噩梦，但对很少一部分欧洲人却无法构成威胁。这些人天生携带一种天然的变异基因，可以抵御艾滋病。许特尔最终找到了与这名患者成功配型并携带抗艾变异基因的捐献者，成功实施手术。

　　在接受该骨髓治疗后，这名美国人停止服用抗艾滋药物。3年半后，这名美国病人已不再有白血病和艾滋病病毒感染的迹象。“这一结果非常明确地显示这名患者的艾滋病得到治愈。”施奈德研究团队在报告中宣传。

　　25岁艾滋患者可活八十岁

　　这一医学奇迹燃起不少艾滋病病毒携带者康复的希望。对于这个治疗，英国伯明翰艾滋中心的迈克·桑阿格给予很高的评价，“这是具有重要意义的科学研究”。桑阿格表示，在理论上已经证实这种变异基因能够抵抗艾滋病病毒，并且曾在白鼠体内试验过，但是这是首次科学家在人体上实验，证明这个基因能治疗艾滋病。

　　桑阿格表示这种治疗方法可以为艾滋病患者延长寿命，“如果一名病人25岁患有艾滋病，那么他将可能会活到八十，甚至九十岁。这为艾滋病的治疗提供了一条新的道路。”

　　编译 危凯

　　科学家研制

　　人工抗艾突变基因

　　一些生物学和医学学者说，这一奇迹几乎不可复制。一方面，骨髓移植伴有相当大的风险。另外，找寻具有抗艾基因的配型者无异于海底捞针。

　　美国艾滋病病毒医学协会前会长迈克尔·扎格认为，干细胞或骨髓移植必须要利用强力药物和放射物摧毁人体原有的免疫系统，然后输入捐献者的骨髓，以重造一个新的免疫系统，这种疗法及其引发的并发症会提高死亡率。另外，治疗费用太高，大概需要几千万美元。更难的是，找到一个合适的、具有抗艾基因的骨髓很困难，这一基因突变只存在于生活在北欧和西欧的高加索人中，且只占到其总人口的1%。

　　美国南加州大学生物学教授坎农提出一个大胆设想：“既然难以移植抗艾变异基因，那是否能实现人造呢？”坎农及其研究团队正在试验鼠上进行此项试验，并取得了一定进展。

American men were successfully cured of AIDS
    http://www.sina.com.cn 2010 年 12 月 17 日 16:24 Changjiang Times
Now network news as a damaged immune system disease, AIDS has been the medical problems afflicting the world, there is no an effective way to cure it. However, according to the Associated Press reported December 15, German researchers have in the new American "blood" magazine published report that they successfully treated by bone marrow transplantation therapy in patients with AIDS, of a leukemia. However, this therapy can promote controversy.

Bone marrow transplantation cure AIDS

Researchers in Germany 柏林沙里泰 hospital, said Thomas Schneider, a 40-year-old American leukemia patients receiving bone marrow transplant in 2007 intended. He is also an AIDS virus. This patient's attending physician Xu Patel was a bold idea emerged: "Why not both at the same time to cure disease?"

In fact, despite the AIDS nightmare for some people means, but for a fraction of but can not pose a threat to the Europeans. These people are born to carry a natural genetic variation that can combat AIDS. Hsu Patel finally found success with these patients with type and variant genes carrying resistance to AIDS donors, successful implementation of the operation.

In an interview with the bone marrow treatment, the Americans to stop taking anti-HIV drugs. 3 and a half years later, the United States no longer has leukemia patients and signs of HIV infection. "This result very clearly shows that AIDS patients have been cured." Schneider publicity team in the report.

25-year-old AIDS patient can live eighty years old

This medical miracle to light many people with HIV hope of recovery. For this treatment, HIV Center 迈克桑阿格 Birmingham spoke highly of, "This is important for scientific research." Sang Age that, in theory, have confirmed that this variant resistant to HIV, and tested in vivo in mice, but this is the first scientist experiments in humans show that this gene to treat AIDS.

Sang Age that this treatment can prolong life for AIDS patients, "If a patient with AIDS 25 years old, he will probably live to eighty, or even nine years old. This is the treatment of AIDS and provide a new the road. "

Wei Kai compile

Scientists

Ai artificial anti-mutant

Some scholars say that biology and medicine, the miracle almost impossible to copy. On the one hand, bone marrow transplantation associated with considerable risk. In addition, with anti-Ikea looking for the matching are tantamount to Haidilaozhen.

American Medical Association, former president of the AIDS virus that Michael Zag, stem cell or bone marrow transplants must take advantage of powerful drugs and radiation to destroy the original body's immune system, then enter the donor's bone marrow to re-create a new immune system, complications caused by this therapy will increase their mortality. In addition, the high cost of treatment takes about tens of millions of dollars. More difficult is to find a suitable, with anti-Ikea is difficult because of the bone marrow, the gene mutation exists only in living in the northern and western Europe Caucasians, and up only 1% of the total population.

Professor of biology at the University of Southern California, Cannon made a bold vision: "Since the anti-AIDS gene variant is difficult to transplant, it is artificial to achieve it?" Cannon and his team are experimenting with mice on the test, and made some progress.

　
 
 
 
　

［ 作者：佚名    转贴自：本站原创    点击数：196    更新时间：2010-12-18    文章录入：nnb ］

　

同时患艾滋病和白血病的美国男子骨髓移植后“起死回生” 变异基因打开“抗艾”新思路 康生丹因免疫调控治疗艾滋病

 
　
　
　
 

同时患艾滋病和白血病的美国男子骨髓移植后“起死回生”变异基因打开“抗艾”新思路 康生丹因免疫调控治疗艾滋病

日期：2010-12-18 作者：叶松亭 来源：文汇报

　
图示∶2010年12月即将出版的《中国特色医疗金鉴》登载的刘君主任及其机构　
　
 

慢性艾滋病早期中医药治疗保障生命论证
 

 
                       
 

    近日，一则消息轰动了国际艾滋病学界：一名同时患有艾滋病和急性白血病的中年美国男子，在2007年接受了骨髓造血干细胞移植手术后，不仅治愈了白血病，体内的艾滋病毒竟也全部消失。专家们认为，虽然骨髓移植风险巨大，病例中所使用的办法目前还无法推广，但这一“特例”为学界提供了新的研究思路。
   
    据柏林研究人员发表在最新一期学术期刊《血液》上的文章，这名美国男子“起死回生”的关键在于他所接受的来自他人的骨髓造血干细胞。为这名美国男子提供干细胞的捐赠者，体内携带一种罕见的变异基因，这种变异基因能够为人体提供针对艾滋病毒的天然抵抗力。
   
    这种名叫“德尔塔32”的变异基因，可以在大约1%的欧洲人体内找到，能够阻止人体内的CCR5蛋白出现在细胞膜表面。由于艾滋病毒需要通过CCR5蛋白才能侵入细胞内部，因此，在有“德尔塔32”存在的人体内，艾滋病毒就无法感染细胞。正是“德尔塔32”逼使这名美国男子体内的艾滋病毒“无用武之地”。
   
    英国诺丁汉大学教授鲍尔表示，其实研究人员早于10年前就已知晓了这一抗病毒原理，“但这是第一次将原理变成现实”。而澳大利亚国家艾滋病流行病学与临床研究中心负责人多诺万教授提醒说：“干细胞移植是一种高端且昂贵的治疗方法，目前我只推荐那些同时患有白血病和艾滋病的病人使用这种治疗方法，无法保证对每名艾滋病患者都有效。”  本报见习记者  叶松亭

    新闻点评∶源于以上研究的证实，免疫恢复是康复艾滋病的根本。刘君教授发明的治疗艾滋病新药康生丹系列产品，自1993年科研至2002年临床应用以来，在激活免疫应答反应系统与提升患者CD4、杀灭HIV等药理作用下，拯救了无数的患者生命；不也是免疫造福患者的佐证吗？
    刘君 协和专家门诊部艾滋病治疗中心主任、教授、专家,中医药疑难病专治网站长等。论文《艾滋病中医论治探析》登载《中国性病艾滋病》2003版杂志,发明的艾滋病治疗新药康生丹自2002年临床应用至今疗效显著，现有中国唯一艾滋病新药3代--康生丹颗粒、4代康生丹--三合皂甙胶囊〔中药化学单体提取99.99%〕对外服务；治疗咨询15809294481〔业务繁忙短信约定为先〕。

At the same time suffering from AIDS and leukemia after bone marrow transplantation American men "back to life" mutated gene open the "anti-AIDS" new ideas Kang Sheng AIDS treatment for immune regulation

Date :2010-12-18 of: Ye Songting Source: Wen Wei Po
 
                       
 

    Recently, a news sensation in the international AIDS community: one with AIDS and acute leukemia, while middle-aged American man, in 2007, received a bone marrow hematopoietic stem cell transplantation, not only cured the leukemia, the body of HIV, had all disappear. Experts believe that, although the risk of bone marrow transplantation huge case approach used in the present can not promote, but this "special case" for academic provides a new idea.
    
    According to the researchers in Berlin, published in the latest issue of journal "Blood" on the article, this U.S. men "back to life," the key is that he accepted from the bone marrow hematopoietic stem cells of others. For the provision of a U.S. man, donor stem cells, the body carried a rare gene variant, this variant can be provided for the human body's natural defenses against HIV.
    
    This is called "Delta 32" gene variation, you can in about 1% of Europeans find the body, the body can prevent CCR5 protein in the cell membrane surface. Because CCR5 protein of HIV need to be penetrated inside the cells, therefore, the "Delta 32" exists in the human body, HIV can not infect cells. It is "Delta 32" to force the body of a U.S. man of HIV, "useless."
    
    Professor at the University of Nottingham, said Powell, in fact, researchers have known as early as 10 years ago this anti-virus principle, "but this is the first time the principle into reality." The Australian National HIV Epidemiology and Clinical Research Center, Professor Donovan cautioned that: "Stem cell transplantation is a treatment for high-end and expensive, now I only recommend those that AIDS patients suffering from leukemia and use of this treatment, can not guarantee is valid for each AIDS. "newspaper trainee reporter Ye Songting

    News Comments: from the above study confirmed that immune recovery is the recovery of AIDS at all. Professor Liu Jun Kang Sheng invented the treatment of AIDS drug products, from 1993 to 2002, clinical application of scientific research since the activation of immune response system and improve patient CD4, kill HIV and other pharmacological effects, the save countless lives of patients; not also benefit patients with immune support it?
    Liu Jun Union experts director of the Center AIDS treatment clinics, professors, experts, Chinese medicine and long difficult disease cures website. Paper "on the Treatment of AIDS medicine," published in "China STD & AIDS" 2003 version of the magazine, Kang Sheng invented the AIDS treatment drug clinical application since 2002, has a significant effect, the only current generation of AIDS drugs 3 - Kang Sheng particles, 4 on behalf of Kang Sheng - triple saponin monomers of Chinese medicine extract capsules 〔〕 99.99% of foreign services; treatment business consulting 15809294481 〔〕 busy message for the first contract.
　
 
 
 
　

［ 作者：佚名    转贴自：本站原创    点击数：197    更新时间：2010-12-18    文章录入：nnb ］